New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Range Of
 

The first oral, broad-spectrum angiogenesis inhibitor, specially formulated through nanotechnology, shows promising anticancer results....(excerpt)

Because it is nontoxic and can be taken orally, the drug, called Lodamin, may be useful as a preventive therapy for patients at high risk for cancer or as a chronic maintenance therapy for a variety of cancers, preventing tumors from forming or recurring by blocking the growth of blood vessels to feed them....

http://www.sciencedaily.com/releases...0630114209.htm

Re: New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Rang
 

In vivo evaluation of microspheres containing the angiogenesis inhibitor, TNP-470, and the metastasis suppression with liver metastatic model implanted neuroblastoma.
Yasuda C, Sakata S, Kakinoki S, Takeyama Y, Ohyanagi H, Shiozaki H.
Pathophysiology. 2009 Jun 18. [Epub ahead of print]PMID: 19540735 [PubMed - as supplied by publisher]Related articles

<input name="EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsP anel.Pubmed_RVDocSum.uid" sid="6" id="UidCheckBox19381291" value="19381291" type="checkbox">6.
Targeting angiogenesis-dependent calcified neoplasms using combined polymer therapeutics.
Segal E, Pan H, Ofek P, Udagawa T, Kopecková P, Kopecek J, Satchi-Fainaro R.
PLoS One. 2009;4(4):e5233. Epub 2009 Apr 21.PMID: 19381291 [PubMed - indexed for MEDLINE]Related articlesFree article

Re: New Oral Angiogenesis Inhibitor Offers Potential Nontoxic Therapy For A Wide Rang
 

Aaagh! Frustration again. Another promising strategy but NO clinical trials. These things take soooo long!

Ellie